A small number of low-cost and generic drugs have extensive human use and safety data, but also a sizable, compelling body of animal study evidence to suggest a likely modest slowing of aging, e.g. rapamycin, or that demonstrates the ability to target a mechanism of aging to reverse age-related disease, e.g. the dasatinib and quercetin,...